ZAIMARA — HIV prevention and support for Zambian adolescent girls and young women

ZAIMARA: Zambian Informed Motivated Aware and Responsible Adolescents and Adults

NIH-funded research Centre for Infectious Disease Research · NIH-11174585

This program compares a tailored HIV prevention and mental-health support package to general health education to help adolescent girls and young women in Zambia get tested, reduce new infections, and access PrEP.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionCentre for Infectious Disease Research NIH-funded
Lab location1 site (Lusaka, Zambia)
Project IDNIH-11174585 on NIH RePORTER

What this research studies

You would join group sessions delivered by trained peer leaders who will teach HIV prevention, support HIV testing, and share information about PrEP and STI prevention. The program (ZAIMARA) was adapted from a proven South African approach and will be tested against a general health promotion program in two randomized groups. Researchers will collect HIV and STI test results and ask about sexual behavior and PrEP use at enrollment and about six months later. The study also screens and refers peer leaders for mental-health needs to help keep the program sustainable in local clinics.

Who could benefit from this research

Good fit: Adolescent girls and young women in Zambia who are sexually active or otherwise at risk for HIV and who can attend the intervention sessions and follow-up visits are ideal candidates.

Not a fit: Young men, people living outside Zambia, or individuals who already know they are HIV-positive and are on stable treatment may not benefit from this prevention-focused program.

Why it matters

Potential benefit: If successful, ZAIMARA could increase HIV testing and PrEP uptake and lower new STIs/HIV while improving mental-health support for peer leaders among adolescent girls and young women in Zambia.

How similar studies have performed: Related IMARA programs adapted for South Africa showed promising effects on STI rates, sexual risk behaviors, PrEP uptake, and mental health, though this is the first full adaptation and implementation trial for Zambia.

Where this research is happening

Lusaka, Zambia

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Acquired Immune Deficiency Syndrome VirusAcquired Immunodeficiency Syndrome Virus
Last reviewed 2026-06-10 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.